Revolade Tablet - 25 mg

Revolade European Medicines Agency revolade Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated revolade The use of REVOLADE to increase and maintain the platelet count prior to and throughout antiviral treatment of HCV infection gives patients a better opportunity

revolade Les informations sur le médicament REVOLADE 50 mg cp pellic sur VIDAL : Formes et présentations, Composition, Indications, Posologie et mode